stars 1 stars 2 stars 3

DegenRx is a biotech company developing AAV-mediated gene therapy for the treatment of Alzheimer’s disease. Using Adeno-Associated-Viral (AAV) vectors we deliver genes in the brain that initiate the local production of therapeutic antibodies

Website http://www.degenrx.com
Employees 3 (0 on RocketReach)
Founded 2018
Technologies
Industry Biotechnology, Pharmaceutical Manufacturing, Science and Engineering, Drug Discovery, Pharmaceutical, Health Care
Keywords Gene Therapy, Aav Gene Therapy, Biotech, Therapeutic Antibodies, Adeno Associated Virus, Drug Development, Neurodegenerative Diseases, Pharmaceutical, Biotechnology, Drug Discovery, Gene Delivery, Clinical Trials, Therapeutic Proteins, Precision Medicine

DegenRx B.V. Questions

DegenRx B.V. is based in Tilburg, Noord-Brabant.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users